GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $202.97 million versus the consensus estimate of $202.59 million.

GUIDANCE:

GoodRx Holdings, Inc. sees FY2025 revenue of $810-840 million, versus the consensus of $823.3 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.